Review of Dercum’s disease and proposal of diagnostic criteria, diagnostic methods, classification and management

<p>Abstract</p> <p>Definition and clinical picture</p> <p>We propose the minimal definition of Dercum’s disease to be generalised overweight or obesity in combination with painful adipose tissue. The associated symptoms in Dercum’s disease include fatty deposits, easy b...

Full description

Bibliographic Details
Main Authors: Hansson Emma, Svensson Henry, Brorson Håkan
Format: Article
Language:English
Published: BMC 2012-04-01
Series:Orphanet Journal of Rare Diseases
Subjects:
Online Access:http://www.ojrd.com/content/7/1/23
id doaj-111f70a8e2b640cd8d851132d17c855f
record_format Article
spelling doaj-111f70a8e2b640cd8d851132d17c855f2020-11-25T00:30:00ZengBMCOrphanet Journal of Rare Diseases1750-11722012-04-01712310.1186/1750-1172-7-23Review of Dercum’s disease and proposal of diagnostic criteria, diagnostic methods, classification and managementHansson EmmaSvensson HenryBrorson Håkan<p>Abstract</p> <p>Definition and clinical picture</p> <p>We propose the minimal definition of Dercum’s disease to be generalised overweight or obesity in combination with painful adipose tissue. The associated symptoms in Dercum’s disease include fatty deposits, easy bruisability, sleep disturbances, impaired memory, depression, difficulty concentrating, anxiety, rapid heartbeat, shortness of breath, diabetes, bloating, constipation, fatigue, weakness and joint aches.</p> <p>Classification</p> <p>We suggest that Dercum’s disease is classified into: I. <it>Generalised diffuse form</it> A form with diffusely widespread painful adipose tissue without clear lipomas, II. <it>Generalised nodular form</it> - a form with general pain in adipose tissue and intense pain in and around multiple lipomas, and III. <it>Localised nodular form</it> - a form with pain in and around multiple lipomas IV. <it>Juxtaarticular form</it> - a form with solitary deposits of excess fat for example at the medial aspect of the knee.</p> <p>Epidemiology</p> <p>Dercum’s disease most commonly appears between the ages of 35 and 50 years and is five to thirty times more common in women than in men. The prevalence of Dercum’s disease has not yet been exactly established.</p> <p>Aetiology</p> <p>Proposed, but unconfirmed aetiologies include: nervous system dysfunction, mechanical pressure on nerves, adipose tissue dysfunction and trauma.</p> <p>Diagnosis and diagnostic methods</p> <p>Diagnosis is based on clinical criteria and should be made by systematic physical examination and thorough exclusion of differential diagnoses. Advisably, the diagnosis should be made by a physician with a broad experience of patients with painful conditions and knowledge of family medicine, internal medicine or pain management. The diagnosis should only be made when the differential diagnoses have been excluded.</p> <p>Differential diagnosis</p> <p>Differential diagnoses include: fibromyalgia, lipoedema, panniculitis, endocrine disorders, primary psychiatric disorders, multiple symmetric lipomatosis, familial multiple lipomatosis, and adipose tissue tumours.</p> <p>Genetic counselling</p> <p>The majority of the cases of Dercum’s disease occur sporadically. A to G mutation at position A8344 of mitochondrial DNA cannot be detected in patients with Dercum’s disease. HLA (human leukocyte antigen) typing has not revealed any correlation between typical antigens and the presence of the condition.</p> <p>Management and treatment</p> <p>The following treatments have lead to some pain reduction in patients with Dercum’s disease: Liposuction, analgesics, lidocaine, methotrexate and infliximab, interferon α-2b, corticosteroids, calcium-channel modulators and rapid cycling hypobaric pressure. As none of the treatments have led to long lasting complete pain reduction and revolutionary results, we propose that Dercum’s disease should be treated in multidisciplinary teams specialised in chronic pain.</p> <p>Prognosis</p> <p>The pain in Dercum’s disease seems to be relatively constant over time.</p> http://www.ojrd.com/content/7/1/23Dercum’s diseaseAdiposis dolorosaAdiposalgiaChronic painAdipose tissueDiagnostic criteria
collection DOAJ
language English
format Article
sources DOAJ
author Hansson Emma
Svensson Henry
Brorson Håkan
spellingShingle Hansson Emma
Svensson Henry
Brorson Håkan
Review of Dercum’s disease and proposal of diagnostic criteria, diagnostic methods, classification and management
Orphanet Journal of Rare Diseases
Dercum’s disease
Adiposis dolorosa
Adiposalgia
Chronic pain
Adipose tissue
Diagnostic criteria
author_facet Hansson Emma
Svensson Henry
Brorson Håkan
author_sort Hansson Emma
title Review of Dercum’s disease and proposal of diagnostic criteria, diagnostic methods, classification and management
title_short Review of Dercum’s disease and proposal of diagnostic criteria, diagnostic methods, classification and management
title_full Review of Dercum’s disease and proposal of diagnostic criteria, diagnostic methods, classification and management
title_fullStr Review of Dercum’s disease and proposal of diagnostic criteria, diagnostic methods, classification and management
title_full_unstemmed Review of Dercum’s disease and proposal of diagnostic criteria, diagnostic methods, classification and management
title_sort review of dercum’s disease and proposal of diagnostic criteria, diagnostic methods, classification and management
publisher BMC
series Orphanet Journal of Rare Diseases
issn 1750-1172
publishDate 2012-04-01
description <p>Abstract</p> <p>Definition and clinical picture</p> <p>We propose the minimal definition of Dercum’s disease to be generalised overweight or obesity in combination with painful adipose tissue. The associated symptoms in Dercum’s disease include fatty deposits, easy bruisability, sleep disturbances, impaired memory, depression, difficulty concentrating, anxiety, rapid heartbeat, shortness of breath, diabetes, bloating, constipation, fatigue, weakness and joint aches.</p> <p>Classification</p> <p>We suggest that Dercum’s disease is classified into: I. <it>Generalised diffuse form</it> A form with diffusely widespread painful adipose tissue without clear lipomas, II. <it>Generalised nodular form</it> - a form with general pain in adipose tissue and intense pain in and around multiple lipomas, and III. <it>Localised nodular form</it> - a form with pain in and around multiple lipomas IV. <it>Juxtaarticular form</it> - a form with solitary deposits of excess fat for example at the medial aspect of the knee.</p> <p>Epidemiology</p> <p>Dercum’s disease most commonly appears between the ages of 35 and 50 years and is five to thirty times more common in women than in men. The prevalence of Dercum’s disease has not yet been exactly established.</p> <p>Aetiology</p> <p>Proposed, but unconfirmed aetiologies include: nervous system dysfunction, mechanical pressure on nerves, adipose tissue dysfunction and trauma.</p> <p>Diagnosis and diagnostic methods</p> <p>Diagnosis is based on clinical criteria and should be made by systematic physical examination and thorough exclusion of differential diagnoses. Advisably, the diagnosis should be made by a physician with a broad experience of patients with painful conditions and knowledge of family medicine, internal medicine or pain management. The diagnosis should only be made when the differential diagnoses have been excluded.</p> <p>Differential diagnosis</p> <p>Differential diagnoses include: fibromyalgia, lipoedema, panniculitis, endocrine disorders, primary psychiatric disorders, multiple symmetric lipomatosis, familial multiple lipomatosis, and adipose tissue tumours.</p> <p>Genetic counselling</p> <p>The majority of the cases of Dercum’s disease occur sporadically. A to G mutation at position A8344 of mitochondrial DNA cannot be detected in patients with Dercum’s disease. HLA (human leukocyte antigen) typing has not revealed any correlation between typical antigens and the presence of the condition.</p> <p>Management and treatment</p> <p>The following treatments have lead to some pain reduction in patients with Dercum’s disease: Liposuction, analgesics, lidocaine, methotrexate and infliximab, interferon α-2b, corticosteroids, calcium-channel modulators and rapid cycling hypobaric pressure. As none of the treatments have led to long lasting complete pain reduction and revolutionary results, we propose that Dercum’s disease should be treated in multidisciplinary teams specialised in chronic pain.</p> <p>Prognosis</p> <p>The pain in Dercum’s disease seems to be relatively constant over time.</p>
topic Dercum’s disease
Adiposis dolorosa
Adiposalgia
Chronic pain
Adipose tissue
Diagnostic criteria
url http://www.ojrd.com/content/7/1/23
work_keys_str_mv AT hanssonemma reviewofdercumsdiseaseandproposalofdiagnosticcriteriadiagnosticmethodsclassificationandmanagement
AT svenssonhenry reviewofdercumsdiseaseandproposalofdiagnosticcriteriadiagnosticmethodsclassificationandmanagement
AT brorsonhakan reviewofdercumsdiseaseandproposalofdiagnosticcriteriadiagnosticmethodsclassificationandmanagement
_version_ 1725328527509684224